Risk stratification in normotensive acute pulmonary embolism patients: focus on the intermediate–high risk subgroup

Abstract

Risk stratification in normotensive pulmonary embolism should consider the cumulative presence of cardiac biomarkers and imaging signs of right ventricular dysfunction, especially in the intermediate-high risk subgroup.